For Patients

Learn About Our Clinical Trials

Oncternal is committed to advancing our pipeline and bringing patients a new wave of novel cancer therapies. Clinical trials are an important part of that process. We are currently enrolling clinical trials to understand the potential therapeutic benefit our product candidate might provide, to help researchers understand how to best use them, and determine the best path to ultimately gain regulatory approval.

Cirmtuzumab

A Study of Cirmtuzumab and Ibrutinib in Patients with B-Cell Lymphoid Malignancies

Study of Cirmtuzumab and Paclitaxel for Metastatic or Locally Advanced, Unresectable Breast Cancer

TK216

TK216 in Patients With Relapsed or Refractory Ewing Sarcoma